It’s true that we’ve come a long way in recent years when it comes to treating multiple ... Black patients. 6 The pressing question here is ‘what’s behind this?’. The International ...

“It was helpful to understand the various classes of drugs to treat multiple myeloma and what to expect,” Evelyn says. Evelyn’s journey to getting a diagnosis began when she started experiencing pain ...

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) today announced an option to license agreement to develop SIM0500, an investigational new drug candidate.

are bispecific antibodies that activate T cells by targeting CD3 and that have been approved for the treatment of triple-class–exposed relapsed or refractory multiple myeloma. A total of 94 ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

Forty-eight patients with multiple myeloma, most of them ambulatory outpatients, at 5 co-operating hospitals,‡ were treated. Patients were entered in the double-blind study by randomized card ...

Cooperative efforts were required to obtain and analyze clinical trial data from multiple sponsors and to determine the best approach to analysis with a relatively limited number of available datasets ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

Source: Science Source Images The IFM2017-03 trial, which showed positive results with a dexamethasone-sparing regimen, is “one of the most practice-changing” studies presented at ASH 2024 ...

Recently, on Reddit, a young Black man who grew up in a white family ... Let People Ask Her Anything About Her Experience, And It's Eye-OpeningMegan Liscomb · Dec. 3, 2024 19 Heartbreaking ...